Latest AI and machine learning research in other cancers for healthcare professionals.
FDG-PET/CT is central to Lugano-based staging, Deauville-scored response assessment, and prognostication across Hodgkin and non-Hodgkin lymphoma subtypes. Quantitative metrics, particularly total metabolic tumor volume, have emerged as powerful independent prognostic biomarkers. In Hodgkin's lymphoma, interim PET successfully guides treatment de-escalation, while in DLBCL, interim PET remains prog...
While effective against non-small cell lung cancer (NSCLC), PD-1 inhibitors can induce immune-related adverse events (irAEs), occurring in up to 15.2% of patients and potentially fatal. Currently, effective predictive biomarkers capable of simultaneously forecasting both irAEs and immune checkpoint inhibitor (ICI) responders remain elusive. This limitation hinders the safe clinical application of ...
Extracellular vesicles (EVs) have emerged as promising tools for early cancer detection, therapeutic monitoring, and drug delivery in oncology. Artifi...
Targeted protein degradation (TPD) has emerged as a transformative therapeutic strategy that offers unprecedented opportunities to eliminate tradition...
AIM: Germline BRCA1/2 pathogenic variant carriers are at increased risk for high-grade serous carcinoma (HGSC) and are therefore advised to have a ris...
INTRODUCTION: This study aimed to develop radiomics-based multivariate classifiers able to non-invasively decipher the tumor immune microenvironment (...
Cancer immunotherapy has transformed the treatment landscape across multiple malignancies; however, durable responses remain limited to a subset of pa...
Chromosomal instability (CIN) drives clear cell renal cell carcinoma (ccRCC) progression, yet its upstream triggers remain elusive. To identify key dr...
INTRODUCTION: Salivary gland tumors (SGTs) comprise a heterogeneous group of neoplasms with diverse histopathological and molecular features. AIM: Thi...
BACKGROUND: In pediatric surgical oncology, intraoperative tissue assessment is limited by small specimen size and the absence of real time histopatho...
RATIONALE AND OBJECTIVES: We aimed to establish a Segment Anything Model 3 (SAM3) based on ultrasound images for automatic papillary thyroid microcarc...
BACKGROUND: Laslo et al. recently reported a guided denoising diffusion implicit model for spatial tumor growth prediction on magnetic resonance imagi...
Tumor immunotherapy has emerged as a transformative strategy for cancer treatment. However, its clinical efficacy remains limited by the immunosuppres...
BACKGROUND: Bladder cancer is the most common malignancy of the urinary tract and is often treated with radical cystectomy with lymph node dissection,...
Hepatocellular carcinoma (HCC) is a malignancy with high global incidence and mortality, whose significant heterogeneity and poor prognosis pose sever...
Multiparameter flow cytometry is essential for diagnosing mature B-cell lymphomas, yet analysis remains largely manual, time-consuming, and subject to...
OBJECTIVE: To develop an intelligent diagnostic model based on a Local-Higher Order Graph Neural Network (LHGNN) to achieve noninvasive auxiliary mult...
High-throughput screening (HTS) remains the cornerstone of early phase small molecule discovery yet consistently underperforms against immunotherapy t...
Esophageal cancer is biologically heterogeneous, and conventional clinicopathological staging incompletely captures variation in patient outcomes. Thi...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by multifactorial pathology, including amyloid-β (Aβ) aggregation, ...